Cephalosporins: bridging the generation gap.
More than a dozen compounds are now available. Although very effective and generally safe, the cephalosporins are often misused. The second- and third-generation drugs have provided progressively wider spectra of activity, although none has surpassed the activity of cephalothin against beta-lactamase-producing staphylococci. Cefotaxime and moxalactam have been shown to be useful in meningitis, whereas most of their predecessors have shown poor penetration into the cerebrospinal fluid.